BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 4005802)

  • 21. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
    Reed W; Bøhler PJ; Sandstad B; Nesland JM
    Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis.
    Shao GL; Wang MC; Fan XL; Zhong L; Ji SF; Sang G; Wang S
    Technol Cancer Res Treat; 2018 Jan; 17():1533034617754024. PubMed ID: 29529946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?
    Rack B; Janni W; Gerber B; Strobl B; Schindlbeck C; Klanner E; Rammel G; Sommer H; Dimpfl T; Friese K
    Breast Cancer Res Treat; 2003 Nov; 82(2):83-92. PubMed ID: 14692652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors in axillary lymph node-negative (pN-) breast carcinomas.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    Eur J Cancer; 1991; 27(12):1555-9. PubMed ID: 1782062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reasoning with uncertainty in pathology: artificial neural networks and logistic regression as tools for prediction of lymph node status in breast cancer patients.
    Marchevsky AM; Shah S; Patel S
    Mod Pathol; 1999 May; 12(5):505-13. PubMed ID: 10349989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer.
    Takei H; Suemasu K; Kurosumi M; Horii Y; Ninomiya J; Yoshida M; Hagiwara Y; Inoue K; Tabei T
    Breast J; 2006; 12(5 Suppl 2):S157-64. PubMed ID: 16958996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189.
    Simpson JF; Gray R; Dressler LG; Cobau CD; Falkson CI; Gilchrist KW; Pandya KJ; Page DL; Robert NJ
    J Clin Oncol; 2000 May; 18(10):2059-69. PubMed ID: 10811671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancer.
    Eskelinen M; Lipponen P; Papinaho S; Aaltomaa S; Kosma VM; Klemi P; Syrjänen K
    Int J Cancer; 1992 Jun; 51(4):555-61. PubMed ID: 1601520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.
    Janssen EA; Baak JP; Guervós MA; van Diest PJ; Jiwa M; Hermsen MA
    J Pathol; 2003 Dec; 201(4):555-61. PubMed ID: 14648658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breast-cancer patients with long follow-up.
    Uyterlinde AM; Baak JP; Schipper NW; Peterse H; Matze E; Meijer CJ
    Int J Cancer; 1990 Jan; 45(1):1-7. PubMed ID: 2298493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of nuclear morphology in breast cancer prognosis.
    Wolberg WH; Street WN; Mangasarian OL
    Clin Cancer Res; 1999 Nov; 5(11):3542-8. PubMed ID: 10589770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic significance of nodal ratio on breast cancer recurrence and its potential for incorporation in a new prognostic index.
    Martin FT; O'Fearraigh C; Hanley C; Curran C; Sweeney KJ; Kerin MJ
    Breast J; 2013; 19(4):388-93. PubMed ID: 23721403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of extent of disease and morphometric and DNA flow cytometric prognostic factors in invasive ductal breast cancer.
    Uyterlinde AM; Schipper NW; Baak JP
    J Clin Pathol; 1987 Dec; 40(12):1432-6. PubMed ID: 2828434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome.
    Camp RL; Rimm EB; Rimm DL
    Cancer; 2000 Jan; 88(1):108-13. PubMed ID: 10618612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.
    Hatoum HA; Jamali FR; El-Saghir NS; Musallam KM; Seoud M; Dimassi H; Abbas J; Khalife M; Boulos FI; Tawil AN; Geara FB; Salem Z; Shamseddine AA; Al-Feghali K; Shamseddine AI
    Ann Surg Oncol; 2009 Dec; 16(12):3388-95. PubMed ID: 19655200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proliferating cell nuclear antigen (PCNA) immunolabeling as a prognostic factor in axillary lymph node negative breast cancer.
    Aaltomaa S; Lipponen P; Syrjänen K
    Anticancer Res; 1993; 13(2):533-8. PubMed ID: 8100128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictor.
    Clayton F
    Cancer; 1991 Sep; 68(6):1309-17. PubMed ID: 1651805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.